Our 53rd episode of QuidelOrtho Science Bytes features Dr. Qian Ding, MD, PhD, exploring why early detection of diabetes is a clinical and economic imperative. From identifying silent disease progression to leveraging smarter lab platforms, early testing empowers clinicians to intervene sooner, personalize care and help prevent costly complications. Dr. Ding shares how diagnostics and emerging biomarkers are helping reshape diabetes care – delivering fast, reliable insights that support proactive treatment and healthier outcomes.   About Our Speaker:  Dr. Qian Ding, MD, PhD Dr. Ding brings extensive experience in hospital laboratory and in vitro diagnostics with a strong command of healthcare information systems and data analytics. With a comprehensive background in microbiology, immunology, molecular genetics and healthcare business intelligence, Dr. Ding is also an accomplished researcher with an established record of publications in reputable peer-reviewed scientific journals. She's also recognized as a leader at the intersection of science, technology and healthcare.